Commission implementing Regulation (EU) 2019/2094 of 29 November 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (Text with EEA relevance)

• CELEX: Regulation (EU) 2019/2094
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘31 January 2021’;

(2)

in the sixth column, expiration of approval, of row 81, Pyraclostrobin, the date is replaced by ‘31 January 2021’;

(3)

in the sixth column, expiration of approval, of row 114, Mancozeb, the date is replaced by ‘31 January 2021’;

(4)

in the sixth column, expiration of approval, of row 115, Metiram, the date is replaced by ‘31 January 2021’;

(5)

in the sixth column, expiration of approval, of row 116, Oxamyl, the date is replaced by ‘31 January 2021’;

(6)

in the sixth column, expiration of approval, of row 128, Dimoxystrobin, the date is replaced by ‘31 January 2021’;

(7)

in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘28 February 2021’;

(8)

in the sixth column, expiration of approval, of row 188, Benfluralin, the date is replaced by ‘28 February 2021’;

(9)

in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘28 February 2021’;

(10)

in the sixth column, expiration of approval, of row 191, Mepiquat, the date is replaced by ‘28 February 2021’.